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ABSTRACT The embryotoxicity of the antimalarial drug chloroquine (CQ) 
was evaluated in vitro using the rat whole embryo culture system. CQ was 
found to be embryotoxic and dysmorphogenic when added directly to the culture 
media containing gestational day (GD) 10 rat conceptuses. Twenty-six-hr expo- 
sure to CQ elicited dose-related decreases in embryonic crown-rump length, 
protein and DNA contents and increases in the incidence of morphologically 
abnormal embryos. At 30 pM CQ, embryonic protein content was decreased to 
67% and DNA content to 58% of control while the incidence of morphological 
abnormalities rose to 100%. Abnormal axial rotation, microophthalmia, and 
selective cephalic hypoplasia were the most common developmental abnormal- 
ities observed. Visceral yolk sac (VYS) vasculature and blood pigmentation 
were also decreased in a dose-dependent manner, as was VYS DNA content 
(80% of control a t  30 pM). VYS protein content, however, showed an alternate 
pattern of response, decreasing to 87% of control at 10 pM CQ but increasing t o  
125% of control at 30 pM. Histologic evaluation revealed that the cytoplasm of 
the VYS endoderm epithelium was distended due to vacuolization produced by 
CQ exposure. In the embryo proper, CQ inhibited cranial neural tube develop- 
ment and altered the morphology of cranial neural crest cells. These observa- 
tions document the in vitro embryotoxicity of CQ and suggest altered VYS 
histiotrophic nutrition as well as direct embryonic effects as possible mecha- 
nisms of CQ embryotoxicity. o 1993 Wiley-Liss, Inc 
Chloroquine CCQ) has been used for more 
than forty years as an  antimalarial drug 
and more recently in the treatment of rheu- 
matoid arthritis (RA), systemic lupus 
erythematosis (SLE) and insulin resistant 
diabetes mellitus (Mackenzie, '83; Blazar et 
al., '84). The drug is able to cross the human 
placenta, having been found in human cord 
blood (Eissen and Afamefuna, '82). While 
some authorities recommend CQ as the 
drug of choice for malarial prophylaxis dur- 
ing pregnancy (Briggs et al., 'go), limited 
epidemiologic data are not sufficient to ex- 
clude the possibility that prophylactic doses 
of CQ are teratogenic (Wolfe and Cordero, 
'85). Treatment of SLE and RA with CQ 
during pregnancy raises more concern re- 
garding the potential for human embryotox- 
icity. Dosages for these conditions are typi- 
cally higher than those used in malarial 
prophylaxis and high dose CQ exposure dur- 
ing pregnancy has been more directly asso- 
ciated with human birth defects (Hart and 
Naunton, '64). Levy et al. ('91) also found a 
higher than normal rate of fetal loss, but no 
evidence of congenital malformations, 
among a small sample of women who had 
been treated with CQ for SLE, RA, or  ma- 
larial prophylaxis during the first trimester 
of pregnancy. These authors recommended 
further studies to better assess the potential 
risk of CQ treatment during pregnancy, es- 
pecially with regard to the possible cumula- 
tive effects of CQ administration through- 
out gestation. 
Despite the widespread use of CQ and re- 
ports of human birth defects associated with 
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its usage, few studies have systematically 
investigated mechanisms of CQ embryotox- 
icity in animal models. Udalova ('67) found 
increased resorptions and ocular malforma- 
tions in rats treated with CQ during early 
organogenesis. Long-term administration of 
CQ to pregnant rats has also been reported 
to be teratogenic, resulting in fetal growth 
retardation and various malformations in- 
cluding hepatomegaly, liquifaction of the 
brain and visceral organs and skeletal al- 
terations (Sharma and Rawat, '89). The 
drug has been found to be embryolethal, ter- 
atogenic and capable of synergizing the ter- 
atogenicity of cholinomimetic drugs when 
injected into the yolk sacs of chicken em- 
bryos (Landauer, '78). Several studies have 
demonstrated the ability of CQ to modulate 
the embryotoxicity of other teratogenic 
agents. Yeilding et al., ('76) used an unspec- 
ified nonteratogenic dose of CQ to enhance 
the teratogenic effects of x-rays in mice, 
while Burkard and Fritz-Niggli ('87) found 
CQ protected mice from the teratogenic and 
transplacental carcinogenic effects of ure- 
thane. In the later study, however, only a 
single dose of CQ was given on gestational 
day 14, very late in organogenesis. 
Ongoing studies, directed at  understand- 
ing the relationship between chemical dis- 
ruption of nutritional pathways and dys- 
morphogenesis, led us to evaluate the in 
vitro embryotoxicity of CQ because of its re- 
ported effects on cellular vacuolar systems. 
A number of studies have found that CQ 
and other related amines inhibit lysosomal 
hydrolases (Lie and Schofield, '73; Basu et 
al., '81; Nato et al., '82; Kaiser et al. '85; 
Shimizu and Kawashima, '89) and disrupt 
the endocytotic uptake and vacuolar sorting 
of external macromolecules (King et al., '80; 
Tietze et al., '80; Posner et al., '82; Merion 
and Sly, '83). These effects have most often 
been attributed to increased vacuolar pH 
andior osmotic effects of these compounds, 
although Wibo and Poole ('81) determined 
that CQ could directly and reversibly in- 
hibit cathepsin B1. CQ has also been found 
to inhibit endocytosis and lysosomal func- 
tion in cultured GD 17 rat VYSs (Livesay, et 
al., '80). We hypothesize that CQ may be 
embryotoxic or embryolethal due to an in- 
hibition of the nutritional function of the 
VYS during organogenesis. This process, 
known as histiotrophic nutrition, involves 
endocytosis and lysosomal degradation of 
maternal proteins by the VYS endoderm ep- 
ithelium and the subsequent transfer of 
amino acids to the embryo proper for syn- 
thesis of new proteins (Freeman et al., '81; 
Freeman and Lloyd, '83). Disruption of VYS 
histiotrophic nutrition as a mechanism of 
chemical teratogenesis was first proposed 
by Beck et al., ('67) for the azo dye trypan 
blue. Since that time, the vital nutritive 
role played by the rat VYS prior to the es- 
tablishment of the chorioallantoic placenta 
has been well documented and a number of 
chemical agents have been found whose em- 
bryotoxicity can be attributed to alterations 
of VYS histiotrophic nutrition (for review 
see Beckman et al., '90; Brent et al., '90; 
Freeman, '90; and Lloyd, '90). Thus, any 
chemical capable of inhibiting endocytosis 
andior lysosomal function can be regarded 
as a potential in vivo rodent teratogen. 
The objective of the current study was to  
assess the embryotoxicity and dysmorpho- 
genic potential of CQ in rat whole embryo 
culture. This system allows us to focus on 
the conceptus as a direct target without the 
confounding factors of maternal toxicity 
and metabolism. To our knowledge the em- 
bryotoxicity of CQ has not previously been 
investigated in vitro during organogenesis. 
This report provides data which indicate 
that low doses of CQ are directly embryo- 
toxic and effect embryonic and VYS mor- 
phology in vitro. The implications of these 
data with respect to the possible mecha- 
nisms of CQ teratogenicity are discussed. 
MATERIALS AND METHODS 
Chemicals 
Chloroquine diphosphate (CQ) was ob- 
tained from Sigma Chemical Company (St. 
Louis, Mo.). All other reagents were pur- 
chased from various sources and were of the 
highest quality commercially available. 
Animals 
Time-mated primigravida Sprague-Daw- 
ley rats were obtained from the Reproduc- 
tive Sciences Program Small Animal Core 
Facility, the University of Michigan, on ges- 
tational days 7-9. The morning following 
copulation, as indicated by a sperm positive 
vaginal smear, was designated as gesta- 
tional day zero. Pregnant animals were 
maintained on a 14-hr light/l0-hr dark cy- 
cle and given free access to Purina Rat 
Chow (Ralston Purina) and water until the 
morning of explantation. 
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Embryo culture 
On the morning of GD 10, pregnant dams 
were anesthetized with ether and their 
blood collected from the abdominal aorta. 
The blood was centrifuged, the serum heat- 
inactivated and stored at -20°C for subse- 
quent use in culture media. Uteri were re- 
moved from the dams, placed in warmed 
Hanks balanced salt solution (HBSS, Gibco 
BRL, Gaithersburg, MD) and the implanta- 
tion sites dissected free. Conceptuses were 
carefully removed from the decidual mass 
and Reichert's membrane was opened to al- 
low the embryo to develop properly in cul- 
ture. Conceptuses were placed in 125 ml 
roller bottles containing 33% heat-inacti- 
vated female rat serum in HBSS supple- 
mented with penicillin G (100 IUlml) and 
streptomycin (50 pg/ml). The media had 
been warmed to 37°C and gassed with 20% 
02/5% co2/75% N, prior to addition of con- 
ceptuses. Less than ten conceptuses per bot- 
tle were cultured in a total volume of 15 ml 
culture media. The bottles were sealed and 
placed in a roller incubator overnight, then 
regassed with 95% O,h% CO, on the morn- 
ing of GD 11. Morphological assessments 
took place at 1 PM on GD 11 after approxi- 
mately 26 hr of culture. 
Exposure 
Stock CQ solutions of 15 mgiml were pre- 
pared fresh in sterile HBSS, pH 7.4. The 
stock or vehicle was added directly to the 
culture media just prior to addition of con- 
ceptuses on the morning of GD 10, and ex- 
posure was continuous throughout the cul- 
ture period. 
Assessment 
Following 26 hr in culture, conceptuses 
were removed from their culture bottles, 
rinsed with warm HBSS, and placed in 
dishes containing warm HBSS for assess- 
ment of viability (heartbeat and yolk sac 
circulation) and malformations. Assess- 
ments were performed using a Wild M8 dis- 
secting microscope and conducted blind in 
order to minimize bias. Nonviable concep- 
tuses were excluded from biochemical and 
histological analysis. Yolk sac morphology 
was scored numerically according to the cri- 
teria of Seegmiller et al. ('91), with 0 denot- 
ing a healthy VYS (extensive vitelline vas- 
culature containing numerous pigmented 




Fig. 1. Diagram of Embryonic Head measurements. 
a: Total head length-distance from the dorsal hind- 
brain to  the rostral forebrain when viewed from the 
side. b: Prosencephalon length-distance from the optic 
cup midline to the rostral forebrain when viewed from 
the side. c: Prosencephalon height-distance from the 
caudal forebrain near the primitive mouth to the fore- 
brain-midbrain junction. d Total head width-distance 
between the widest points of the head when viewed from 
behind. This area is the lateral hindbrain region. 
scores of 1-4 to VYS abnormalities of in- 
creasing severity (denoting diminished pig- 
ment, vasculature and circulation). A score 
of 4 indicates an avascular yolk sac without 
visible blood pigment or circulation. Yolk 
sacs were removed by dissection and mea- 
surements taken of crown-rump length and 
head size (Fig. 1) with the aid of an ocular 
micrometer. Embryos with frank alter- 
ations in axial rotation were excluded from 
the crown-rump measurements. The em- 
bryos were evaluated for neural tube clo- 
sure, axial rotation and morphologic abnor- 
malities. The embryos and yolk sacs were 
then placed separately in 1 ml of ice-cold 
sodium phosphate buffer (50 mM, pH 6.0) 
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TABLE 1 .  Chloroquine morphology study data 
Initial 
chloroquine Crown-rump3 
concn % Viability' % Dysmorphic2 (mm) Yolk sac  score' 
10 p M  100 (33133) 24 (8/33)' 3.3 2 0.2 0.2 ? 0.4 
20 pM 100 (35/35) 63 (22/35)' 3.2 2 0.2* 1.4 i 0.8' 
100 (36136)' 2.9 f 0.2** 2.6 ? 0.7' 30 p M  88 (36/41) 
0 (Control) 100 (47147) 4 (2147) 3.4 f 0.2 0.0 i 0.0 
'Number of conceptuses possessing active heartbeat and yolk sac circulation at the end of the culture period/numbt.r cultured. 
Combined data from six experiments. 
'Number of morphologically abnormal embryos at the end of the culture periodhumber cultured. Morphologic abnormalities con- 
sisted of any of the following singly or in combination; abnormal axial rotation, prosencephalic hypoplasia, mesencephalic hypoplasia, 
anopthalmia, microopthalmia, craniofacial blisters, lateral protrusions in the hindbrain, cloiical extrophy. 
'Mean ?SD. 
*Significantly different t,han control by Scheffe test, P<0.05. 
**Significantly different than control by Scheffe test, P <:0.001 
'Significant at P <0.05 by Chi-square. 
TABLE 2. Embryonic head measurements' 
Chloroquine  Total head Prosencephelon Prosencephelon Total head 
concn length lendh heiaht wid th  
0 (Control) 1.7 i 0.1 (42) 0.6 ? 0.1 (42) 0.8 * 0.1 (26) 1.3 f 0.1 (41) 
10 p M  1.7 t 0.1 (33) 0.5 ? 0.1 (33)** 0.8 +- 0.1 (27) 1.3 -t 0.1 (26) 
30 pM 1.3 f 0.1 (36)** 0.4 * 0.1 (29)** 0.6 i 0.1 (22)** 1.3 2 0.1 (30) 20 p M  1.5 * 0.2 (32)** 0.4 f 0.1 (32)** 0.7 -t 0.1 (25)** 1.3 ? 0.1 (25) 
'Measurements were as described in Materials and Methods (see Fig. 1). Data are means ?SD of poled samples (n) from six replicate 
experiments. All categories except total head width showed significant overall differences between treatments by one-way ANOVA. 
**Significantly different than control, P '<0.001 by Scheffe multiple comparison test. 
containing 1 mM ethylenediaminetetraace- 
tic acid (EDTA), ultrasonically disrupted, 
and frozen at -70°C for subsequent protein 
and DNA determinations. 
Protein and DNA assays 
Protein content was determined by the 
method of Bradford ('76) using bovine 
gamma globulin standard and dye reagent 
supplied by BioRad (Richmond, Ca.). The 
assay was modified for microtiter plate as- 
say as described by Stark et al. ('87). DNA 
content was determined by the method of 
Labarca and Paigen ('80) using bovine DNA 
as a standard. 
Histology 
Representative samples of control and 
CQ-treated conceptuses were prepared with 
the assistance of the University of Michigan 
Reproductive Sciences Program Morphology 
Core. Briefly, GD 11.5 embryos and yolk 
sacs were separated, rinsed in ice-cold 0.9% 
NaC1, and placed in Karnovsky's fixative. 
The fixed tissues were later dehydrated in a 
graded ethanol series, embedded in glycol 
methacrylate polymer, and cut in 3-5-pm 
transverse sections. Every fifth section was 
saved and stained with hematoxylin and 
eosin (H&E). Examination and photography 
of the sections was performed by the authors 
a t  the University of Michigan Cell Biology 
Laboratories using a Leitz Orthoplan micro- 
scope with a Wild camera attachment. 
Statistical analysis 
The chi-square test was used to determine 
differences in discrete data (malformation 
rate and yolk sac score). The statistical soft- 
ware package Statview (Abacus Concepts, 
Inc. 1986) was used to analyze continuous 
data. One-way analysis of variance 
(ANOVA) was used to determine overall dif- 
ferences between treatment groups. This 
was followed by the Scheffe test €or multiple 
comparison of individual treatment means 
(EY0.05 were considered significant). 
RESULTS 
Dose-response experiments (0-50 pM) in- 
dicated that CQ was embryotoxic and dys- 
morphogenic when present in the culture 
media of gestational day 10-11 conceptuses 
grown in vitro. Addition of CQ to the culture 
media at concentrations greater than 50 FM 
produced 100% embryolethality when eval- 
uated on day 11. CQ concentrations of 
10-30 pM were chosen for our studies since 
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Fig. 2. Morphology of GD 11.5 embryos at the end of 
the 26-hr culture period Control (left), and embryos ex- 
posed to increasing concentrations of chloroquine in the 
culture media (10, 20, and 30 pM from left to  right). 
Note the dose-related increase in abnormal axial rota- 
Fig. 3. GD 11.5 embryo exposed to 30 p M  CQ in the 
culture media for 26 hr. Note abnormal axial rotation, 
anopthalmia, blistering in the prosencephalon and lack 
of cranial neural tube development. This is an example 
of the more severe effects observed at  this concentration 
of CQ. x37. 
these concentrations were found to elicit 
dysmorphogenesis in vitro while retaining 
viability above 85%. 
Table 1 shows that CQ concentrations in 
the range of 10-30 pM caused significant 
tion and hypoplasia in the cephalic region. Micro- 
opthalmia is evident in the embryo exposed to 30 FM 
CQ. The extraembryonic tissues have been removed for 
photography. x 11. 
dose-dependent increases in VYS score 
(0.2-2.8) and incidence of abnormal devel- 
opment (25-100%); and decreases in embry- 
onic crown-rump length (3.4-2.9 mm). CQ 
significantly reduced VYS vascularization 
and blood pigmentation as  evidenced by the 
increased VYS score (P<0.05). Although all 
the embryos exposed to 30 pM CQ possessed 
an  active heartbeat, several were classified 
as nonviable due to a lack of VYS circula- 
tion. Both the VYS and amnion of treated 
conceptuses became opaque a t  the higher 
CQ concentrations. The most common mor- 
phologic abnormalities observed following 
CQ treatment were craniofacial dysplasia. 
micropthalmia and abnormal axial rotation. 
CQ-induced craniofacial dysplasia consisted 
of hypoplasia of the prosencephalon and pro- 
trusions in the lateral region of the hind- 
brain, in an area just rostra1 to the 1st bran- 
chial arch. These morphologic observations 
were confirmed by embryonic head mea- 
surements (Table 2), which showed a signif- 
icant dose-related decrease in total head 
length and prosencephalon size in CQ ex- 
posed embryos, while total head width did 
not differ significantly from the control in 
any of the treated groups. As the incidence 
of morphologic abnormalities increased, so 
did the severity of the dysmorphogenesis ob- 
served (Fig. 2). At 10 pM CQ, relatively few 
structural malformations were observed 
and their severity was limited. At 30 pM, 
however, CQ was found to be 100% dysmor- 
phogenic in the surviving conceptuses. The 
most severely affected embryos showed 
T
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marked inhibition of axial rotation, ano- 
pthalmia, craniofacial blisters and necrosis 
in the trunk region (Fig. 3) .  
Biochemical growth parameters are pre- 
sented in Figure 4. CQ treatment resulted 
in dose-dependent decreases in both protein 
(67% of control at the highest dose, 
P<O.OOl) and DNA content (58% of control 
at the highest dose, P<O.OOl) in the embryo 
proper. In the VYS, however, a similar pat- 
tern is only evident for DNA content (de- 
creased to 80% of control with 30 pM CQ, 
P<O.OOl) .  Compared to control, VYS pro- 
tein content was significantly decreased in 
the 10 pM group (87% of control, P<0.05), 
not significantly altered in the 20 pM group 
and significantly increased in the 30 pM 
treatment group (125% of control, P < O . O O l ) .  
The most striking histologic changes re- 
sulting from CQ exposure were observed in 
the VYS, where the endoderm epithelium 
displayed a dose-dependent cytoplasmic 
vacuolization. Thirty p M  CQ ellicited ex- 
treme vacuolar swelling which distended 
the cytoplasm of these cells (Fig. 5). The 
swollen vacuoles were observed to contain 
eosinophilic material when stained with he- 
matoxylin and eosin, and are believed to 
represent the site of protein accumulation 
in the VYS of conceptuses exposed to 30 p M  
CQ. Vacuolization also occurred in the 10 
and 20 pM treatment groups (not shown) 
but was less severe than that seen in the 30 
Transverse sections through the head re- 
gion of representative control and 30 pM 
treated embryos are shown in Figure 6. It is 
apparent that CQ delayed cranial neural 
tube development including the develop- 
ment of the optic cup. While the neural ep- 
ithelium of the CQ-treated embryo appears 
to posess normal morphology, its thickness 
appears reduced, especially in the hindbrain 
(control neuroepithelium contained an  aver- 
age of five cell nuclei while the 30 pM 
treated embryo had four). In addition, the 
PM group. 
Fig. 4. DNA and protein contents of GD 11.5 em- 
bryos (A,C) and visceral yolk sacs (B,D) a t  the end of 
the 26-hr culture period. Note the differential pattern of 
response between the embryo and VYS protein con- 
tents. Bars represent means +SD from n = 42 (Con- 
troll; 33 (10 KM); 32 (20 &MI; and 36 (30 pM) samples 
from six replicate experiments. *Significantly different 
than control, P 10.05 by Scheffe multiple comparison 
test. **Significantly different than control, P <0.001 by 
Scheffe multiple comparison test. 
brain vesicles had not developed to the same 
extent as  seen in the control. The forebrain 
of the control embryo had expanded and be- 
gun to develop into the telencephalon while 
the forebrain of the treated embryo was not 
expanded, and remained in a state resem- 
bling a late GD 10 rather than GD 11 fore- 
brain. This lack of cephalic neural tube 
expansion, together with decreased mesen- 
chymal extracellular space, results in 
marked hypoplasia in the cephalic region in 
general. An exception to generalized hy- 
poplasia was observed in the lateral hind- 
brain region, where the primordia of the 
fifth cranial nerve is formed from neural 
crest cell derivatives. In the CQ-treated em- 
bryo, the mesenchyme in these areas con- 
tains aggregations of cells with a charac- 
teristic rounded morphology. The lateral 
protrusions observed externally in this re- 
gion appear to result from these cell aggre- 
gates. These cells in the CQ-treated embryo 
correspond to the primordia of the fifth cra- 
nial nerve seen in the control section, al- 
though their location appears to be dis- 
placed slightly ventral with respect to the 
anterior cardinal vein. Higher magnifi- 
cation of these cells (Figs. 7, 8) reveals 
cytoplasmic vacuolization and a rounded 
morphology that was not evident in the cor- 
responding control cells. It is also clear from 
these micrographs that the extracellular 
space surrounding much of the mesenchyme 
(especially near the forebrain) is reduced in 
the CQ-treated embryo. 
DISCUSSION 
The current study partially characterizes 
the in vitro embryotoxicity of CQ in rats. 
Relatively low concentrations of CQ cause 
growth retardation, dysmorphogenesis and 
embryolethality when added directly to  the 
culture media of day 10-11 rat conceptuses 
grown in vitro. Since CQ has been found t o  
cross the placenta and accumulate in fetal 
tissues of mice (Ullberg et al., '701, our data 
imply that the in vivo rodent teratogenicity 
of CQ may be due to  direct effects of the 
drug on the organogenesis stage conceptus. 
rather than to maternal toxicity alone. 
CQ appears to  preferentially affect rap- 
idly developing tissues in the conceptus. In 
the VYS, CQ treatment dramatically re- 
duced vascularization and blood pigmenta- 
tion. An interesting, yet untested hypothe- 
sis, is that increases in vacuolar pH induced 
by CQ may inhibit the intracellular release 
Fig. 5. Histologic appearance of GD 11.5 control (A) 
and 30 pM CQ-treated (B) VYSs. The basic VYS archi- 
tecture is not altered by CQ treatment; the endoderm 
epithelium (E) is supported by a thin mesothelium (M), 
and contains vitelline vessels. The control endoderm 
cells contain numerous absorptive vacuoles that do not 
stain with H&E. Note the enlarged vacuoles in the CQ- 
treated VYS endoderm that distend the cytoplasm of 
these cells. These vacuoles contain eosinophilic mate- 
rial when stained with H&E and represent the pre- 
sumptive site of increased protein content in the 30 pM 
CQ-treated VYSs. x 300, both micrographs (compare 
nuclear size). 
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Fig. 6 .  Cephalic transverse sections taken through 
the lower optic cup region of control (A) and 30 KM 
CQ-treated (B) embryos at the end of the culture period, 
stained with H&E. Rathke’s pouch (asterisk) is used as 
a landmark to compare sections. The control section is 
cut slightly oblique and therefore appears asymmetric. 
The control shows an  expanded forebrain (FBI, well- 
developed optic vesicles (0) and elongated cranial neu- 
ral crest derivatives (arrow). The forebrain of the CQ- 
treated embryo has not expanded and the optic vesicles 
are rudimentary compared to control. The clumps of 
cells lateral to  the anterior cardinal vein in the CQ- 
treated section (arrow) correspond to the cranial neural 
crest in the control section. These cells appear con- 
densed, have a rounded morphology and apparently 
cause the lateral protrusions observed in the hindbrain 
region of CQ-treated embryos. The mesenchyme I M )  of 
the CQ-treated embryo also exhibits reduced extracel- 
M a r  space compared to the control. HB, hindbrain. 
x 70, both micrographs. 
Fig. 7. Higher magnification of areas lateral to the 
anterior cardinal vein in Fig. 6. This figure shows com- 
parative regions from opposite sides of control (A) and 
30 pM CQ-treated (B) embryos. The area between the 
anterior cardinal vein (CV) and the surface ectoderm 
(SE) contains presumptive cranial neural crest deriva- 
tives (primordia of the fifth cranial nerve). Many 
control cells appear elongated and are separated by ex- 
tracellular spaces. The crest cells in the CQ-treated sec- 
tion appear slightly displaced ventrally, display a 
rounded morphology, and appear clumped with little 
extracellular space. NE, hindbrain neural epithelium. 
x 410, both micrographs. 
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Fig. 8. Presumptive cranial neural crest derivatives 
from the lateral hindbrain region of control (A) and 30 
pM CQ-treated (B) embryos. The control cells show uni- 
form areas of extracellular space surrounding cells with 
a rnesenchymal morphology. The CQ-treated cells ex- 
hibit vacuolated cytoplasm (arrow) and reduced extra- 
cellular space. x 450, both micrographs. E, surface ec- 
toderm. 
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of transferrin-bound iron and subsequently 
decrease the rapid hemoglobin synthesis oc- 
curring in the VYS during organogenesis. 
The intracellular release of iron from recep- 
tor-bound transferrin is dependent upon the 
normally acidic pH of endosomes (for review 
see Mellman et al., '86; Wall and Maack, 
'85). Since CQ treatment has been found to 
rapidly increase vacuolar pH (Okhuma and 
Poole, '78) and inhibit iron release from 
transferrin in cultured fibroblasts (Octave 
et al., '82), it seems plausible that concep- 
tuses cultured in the prescence of CQ may 
be unable to acquire enough iron to support 
VYS hematopoiesis. In the embryo proper, 
craniofacial development and axial develop- 
ment were most affected by conceptal expo- 
sure to CQ. Brain, optic and axial develop- 
ment are also three of the most sensitive 
targets for in vivo teratogenic insult at this 
gestational age (Wilson, '73). Although the 
heart is also a sensitive in vivo target at this 
time, it appeared relatively resistant to CQ 
treatment in vitro. 
Direct exposure to CQ in the culture me- 
dia caused dose-related decreases in most of 
the conceptal growth parameters examined 
in this study. Notable exceptions were VYS 
protein content (decreased a t  10 pM but in- 
creased at 30 pM) and total head width (un- 
changed). These anomalies provide clues as  
to the possible mechanisms of CQ embryo- 
toxicity. Regarding the former, the bio- 
chemical growth parameters presented in 
Figure 4 clearly show a differential pattern 
of response in the embryo versus the VYS. 
While embryonic DNA and protein both de- 
crease with increasing CQ concentrations, 
VYS protein content increases at the high- 
est dose even though the DNA content of the 
same tissues was significantly decreased. 
These data, together with the histologic 
findings of enlarged cytoplasmic vacuoles 
containing eosinophilic material in the en- 
doderm of CQ-treated VYSs, suggest that 
the drug might inhibit VYS lysosomal pro- 
teolysis and therefore histiotrophic nutri- 
tion. Although further experimentation is 
required to validate this hypothesis, it is 
consistent with the known inhibitory effects 
of CQ on lysosomal proteolysis in mamma- 
lian cells (de Duve et al., '74; Livesay et al., 
'80; Libby et  al., '80; Nato et al., '82; Posner 
e t  al., '82; Shimizu and Kawashima, '89) 
and also with the observed effects of other 
embryotoxicants which disrupt lysosomal 
function in the VYS (Freeman and Lloyd, 
'83b; Daston et al., '90; Hunter e t  al., '91). 
These and other previous reports show that 
one of the primary effects of embryotoxi- 
cants which disrupt VYS histiotrophic nu- 
trition is general growth retardation in the 
embryo proper, which is also consistent with 
the data presented here. 
Regarding craniofacial morphology, his- 
tologic findings revealed that the lateral 
protrusions apparent in the cranial region 
of treated embryos were caused by aggre- 
grations of abnormal cells underlying these 
areas. These particular cells correspond to 
cranial neural crest derivatives (primordia 
of the fifth cranial nerve) seen in the same 
region of control embryos. Rounded cell 
morphology and decreased extracellular 
space observed in histologic sections from 
CQ-treated embryos leads to the speculation 
that disruption of cell-extracellular matrix 
interaction might play a role in CQ-induced 
dysmorphogenesis, since such interaction is 
an  important determinant of neural crest 
morphology and motility in vitro (Tucker et 
al., '88; Perris e t  al., '91; Rogers et al., '92). 
Alterations in cranial neural crest cell mi- 
gration (which occurs in the rat during GD 
9-1 1) may affect craniofacial development 
since many of the craniofacial tissues are 
derived from this pluripotent cell popula- 
tion (Tan and Morriss-Kay, '89; reviewed in 
Noden, '88 and Le Dourian, '83). Further 
experiments are needed in order to investi- 
gate this possibility. 
Whether CQ itself directly affects neural 
crest cell migration or differentiation, or 
whether these changes are a result of the 
more indirect effects of CQ on VYS function 
is uncertain. Close examination of the af- 
fected cells show that they are vacuole- 
laden and characteristic of CQ-exposed cells 
in other systems (de Duve et al., '74; Krogs- 
tad and Schlesinger, '86). This suggests a 
possible direct effect of CQ on the embryo 
proper, in addition to VYS effects. 
The media CQ concentrations used in this 
study are an  order of magnitude higher 
than those reached in the serum of patients 
receiving CQ therapy for rheumatologic dis- 
ease (Mackenzie, '83). We cannot yet assess 
the relative sensitivities of rats and humans 
to CQ embryotoxicity and can only specu- 
late that acute overdoses or cumulative ef- 
fects of long-term low dose exposure to CQ 
during pregnancy may also have adverse ef- 
fects on human embryonic development. 
The possible direct effects of CQ on embry- 
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onic cells, specifically the neural crest, sug- 
gest that both direct embryonic and indirect 
VYS effects may be involved in CQ embryo- 
toxicity. 
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